Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as an Adjuvant for Ultrasound Guided Greater Occipital Nerve Block in Children Undergoing Posterior Fossa Tumor
NCT07878156Phase 3Recruiting
- Sponsor
- Children's Cancer Hospital Egypt 57357
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in posterior fossa tumor, sponsored by Children's Cancer Hospital Egypt 57357. Started Dec 2025; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
posterior fossa tumor
Beyond the preview
Go deeper on NCT07878156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07878156.